West Pharmaceutical Services Unveils Integrated Prefillable Syringe System

West Pharmaceutical Services Inc. has had a collaboration with China’s pharmaceutical industry for a long time, and has unveiled the West Synchrony prefillable syringe (PFS) system to drug manufacturers at CPHI & PMEC China 2026. This advanced system combines the syringe barrel, plunger, and needle shield into a single well-oiled system. The company emphasized at the event its impetus to support China’s pharmaceutical industry.

The Chinese pharmaceutical industry is rapidly developing owing to helpful governance and significant investment in the research and development of novel drugs and equipment. Chinese companies have benefitted from these factors, and the results are proof as more and more clinical trials for the development of drugs for a wide range of diseases are taking place. Chinese companies held almost 50% share of drug molecules being sent for human clinical trials in the entire world in Q1 and Q2 in 2025.

The supply chain and development requirements for vaccines and drugs are getting more and more stringent, combined with varying regulatory norms in different regions. This is the reason why reliable partners are ever so important to facilitate the smooth development and scaling of indigenously manufactured medicines across the world. West Pharmaceutical Services Inc. has helped Chinese drug makers for multiple decades, not only in terms of equipment support, but also by providing policy adherence guidance, which varies region to region, as well as helping in technical workflows.

Impact on the Healthcare Industry

According to Precedence Research, the launch of PFS is expected to benefit the global healthcare industry, but will have a more positive impact on the Chinese industry specifically. Such joint ventures combine the expertise of various organizations; for example, Chinese pharma companies have the infrastructure to conduct clinical trials and manufacture drugs, and their partner provides the necessary equipment, as well as technical and regulatory guidance. Such partnerships are necessary due to ever-increasing global competition to achieve approvals and maximum adoption, which is a byproduct of the development of effective, convenient, and cost-effective drugs. Such collaborations help companies to smooth the research and development workflow and optimize the manufacturing procedures. 

Impact on the Syringes Market

The global syringes market size was estimated at USD 26.85 billion in 2025 and is predicted to increase from USD 29.33 billion in 2026 to approximately USD 64.86 billion by 2035, expanding at a CAGR of 9.22% from 2025 to 2035.

According to Precedence Research, the syringe market is expected to benefit from the launch of the PFS because it provides an integrated system that performs multiple tasks in the manufacturing workflow of pharmaceutical companies. It helps companies to speed up their production processes and fine-tune the settings according to their needs.

This launch also emphasizes the importance of long-term comprehensive collaborations, which help organizations utilize the resources, expertise, and experience of each other. Such an example is expected to encourage other global firms to collaborate and help each other to develop and manufacture good-quality medicines. 

Impact on the Medical Devices Market

The global medical devices market size is valued at USD 678.88 billion in 2025 and is projected to increase from USD 719.61 billion in 2026 to approximately USD 1,209.42 billion by 2035, expanding at a CAGR of 5.94% from 2026 to 2035.

According to Precedence Research, the medical devices market will benefit from the launch of the PFS as it sets a benchmark for integrated systems that perform multiple tasks involved in the research and manufacturing of various drugs. Such systems gain importance as the global competition for maximum share of the drug market heats up. Such systems help in precise and rapid production.

Such devices also help companies optimize costs as they can enter long-term bulk buying contracts with a single partner who supplies such high-quality integrated medical solutions instead of sourcing equipment from multiple manufacturers, which involves multiple agreements, licenses, and quality control checks. This ecosystem facilitates pharmaceutical and biotechnology companies to invest a large amount of money in research and development instead of using money in sourcing the equipment. The companies also gain tighter control in terms of quality and quantity through the usage of such comprehensive solutions.

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. provides containment and delivery solutions for injectable drugs to the pharmaceutical and biotechnology companies. The company has collaborated with prominent global drug makers to help them in their manufacturing and delivery workflows. The company provides manufacturing support, regulatory adherence guidance, and analytics solutions to its partners to help them maximize their potential for developing high-quality drugs in a reasonable time period. The company also provides predictive engineering expertise to the factory plants of the pharmaceutical and biotechnology companies. This helps those factory managers to predict if certain manufacturing systems are heading towards failure, and hence avoid catastrophic breakdowns which can have serious financial and worker safety consequences.